EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development

Carla Corvaja, Antonio Passaro, Ilaria Attili, Pamela Trillo Aliaga, Gianluca Spitaleri, Ester Del Signore, Filippo de Marinis

Cancer Treatment Reviews · 2024-11 · 130 · 102824

DOI: 10.1016/j.ctrv.2024.102824 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024-11. Verfasst von Carla Corvaja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy. Hauptthemen laut MEDLINE: ErbB Receptors, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Protein Kinase Inhibitors. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsCarcinoma, Non-Small-Cell LungLung NeoplasmsProtein Kinase InhibitorsMutationHumansAniline CompoundsAcrylamidesDrug Resistance, NeoplasmAntineoplastic AgentsIndolesPyrimidines

Stichwörter der Autor:innen

C797SEGFR mutationNon-small cell lung cancerTyrosine-kinase inhibitors

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanAniline CompoundsAcrylamidesosimertinibAntineoplastic AgentsIndolesPyrimidines

Autor:innen und Institutionen

  • Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy.
  • Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy. Electronic address: Antonio.Passaro@ieo.it.

Förderung

  • Ministry of Health

Zitieren

APA

Corvaja, C., Passaro, A., Attili, I., Aliaga, P. T., Spitaleri, G., Signore, E. D., & de Marinis, F. (2024). Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development. Cancer Treatment Reviews, 130, 102824. https://doi.org/10.1016/j.ctrv.2024.102824

Vancouver

Corvaja C, Passaro A, Attili I, Aliaga PT, Spitaleri G, Signore ED, et al. Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development. Cancer Treatment Reviews. 2024;130:102824. doi:10.1016/j.ctrv.2024.102824

BibTeX
@article{Corvaja2024,
  author = {Corvaja, Carla and Passaro, Antonio and Attili, Ilaria and Aliaga, Pamela Trillo and Spitaleri, Gianluca and Signore, Ester Del and de Marinis, Filippo},
  title = {Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  volume = {130},
  pages = {102824},
  doi = {10.1016/j.ctrv.2024.102824}
}
Kostenlos starten →